Categories
- Active Surveillance
- Announcements
- Ask Dr. Barken
- Biomarker
- Biopsy
- Bone Metastases
- Brachytherapy
- Cancer Stem Cells
- Castration Resistant Prostate Cancer
- CETC
- Checklist
- Choline 11 PET Scan
- Clinical Trials
- Coaching
- Color Doppler Trans-Rectal Ultrasound
- Cryo Immunotherapy
- Cryoablation
- CTC
- Decision Making
- Diagnosis
- Exosome
- Ferumoxytol
- Focal Therapy
- Genome
- HIFU
- High Intensity Foucused Ultrasound
- Hormonal Blockade
- Hormone Refractory Disease
- Imaging
- Immune Therapy
- Intermittent Hormonal Blockade
- Journal Club
- Laser
- LIfe Style
- Liquid Biopsy
- Lymph Nodes
- Markers
- Metastatic Disease
- Metastatic Prostate Cancer Disease
- MRI
- MRI Guided Focal
- Multi Parameteric MRI
- Nutrition
- PCREF Support Group Meeting
- PET scans
- Photodynamic Therapy
- Prevention
- Prognosis
- Prostate Cancer
- PSA
- Radiation Therapy
- Radiation treatment
- Radical Prostatectomy
- Sequential Hormonal Blockade
- Sexual Dysfunction
- Support for Prosatate Cancer
- Survival prostate cancer
- Testosterone
- Theranostics
- Treatments for Prostate Cancer
- Tumor Spheres
- Uncategorized
- Vaccine
Category Archives: Metastatic Prostate Cancer Disease
Theranostics with Dr. Ebrahim Delpassant
Dr. Ebrahim Delpassand from Excel Diagnostics being interviewed by Dr. Israel Barken , the medical director of Prostate Cancer Research and Education Foundation. The topic is Theranostics- Combining diagnostic test with therapy as one intervention. For Questions , you can … Continue reading →
Cryo Immuno Therapy Part 3
Part 3 of the lecture about Cryo Immune Therapy given by Dr. Israel Barken from the Prostate Research and Education Foundation. Dr. Barken describes Cryo immunotherapy. The reasons why there are no consistent immune response after cryoablation are discussed. Suggestions for … Continue reading →
Cryo Immunotherapy Part 1
Dr. Barken presents the history of cryoablation and the new developments in the field of immunology which will create enhancement of the Immune effect on metastatic disease in response to cryoablation of local tumor.
Combining active immunotherapy and immune checkpoint inhibitors in prostate cancer
Phase I study approach of priming the immune system with Prostvac vaccination, intensified immunotherapy with Ipilimumab to further enhance the immune response. This was presented by Hapreet Singh M.D. from the National Cancer Institute. Genentech video explaining the “Security Checkpoint System” … Continue reading →
Early Immune Therapy
For the Ask Dr Barken Call In Show on Tuesday, Nov. 27th at 6pm Pacific Dial 1-877-727-3301 to hear the program and speak with Dr. Barken. You may leave a question before the show by dialing the same number and recording … Continue reading →
Radical Prostatectomy for Prostate Cancer Stage D1
Question of the week: Should a patient with advanced localized prostate cancer consider radical prostatectomy? Dr. Barken Discusses the historical classical papers published in the Journal of Urology in Dec 1990 titled: Management of Stage D1 Adenocarcinoma of the Prostate: … Continue reading →
Continuous versus Intermittent Hormonal Blockade Study
Continuous versus Intermittent Hormonal Blockade. Are survival outcomes equal? Ask Dr Barken Call In Show- Every Tuesday 6PM Pacific Time. Call In and talk live with Dr. Barken.
Noscapine availability and avoiding gynecomastia
Questions Called in to the Ask Dr. Barken Show: 1. Where can I get Noscapine in the United States? 2. For patients on Sequential Androgen Blockade, what is Dr. Barken’s common sense approach to avoiding Gynecomastia? Dr. Barken answers two … Continue reading →
Radical Prostatectomy for Positive Lymph Node and Bone Metastatic Prostate Cancer
Dr. Barken discusses the the role of radical prostatectomy in cases of lymph node and bone metastatic disease and describes the German experience as presented at the recent annual Urological Association Conference in May 2012. For the Ask Dr Barken Call … Continue reading →
Prostate Cancer Pelvic Lymph Nodes – Is there a role for radiation?
Video Blog Presentation: Dr. Barken presents Dr. Mack Roach on the topic of radiation of lymph nodes, presented at the PCRI annual meeting. Mack Roach III, M.D. is Professor and Chairman of Radiation Oncology and Urology at the University of … Continue reading →